Differential Network Analysis Reveals Genetic Effects on Catalepsy Modules

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Iancu, Ovidiu D ^a   Oberbeck, Denesa ^a   Darakjian, Priscila ^b   Kawane, Sunita ^b   Erk, Jason ^a   McWeeney, Shannon ^b   Hitzemann, Robert ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; CROSS BREEDING; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; INBRED STRAIN; MOUSE; NONHUMAN; PHENOTYPE;

ALLELES; ANIMALS; BREEDING; CATALEPSY; CLUSTER ANALYSIS; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC VARIATION; GENOTYPE; MICE; MOLECULAR SEQUENCE ANNOTATION; PHENOTYPE; REPRESSOR PROTEINS; REPRODUCIBILITY OF RESULTS; TUMOR SUPPRESSOR PROTEINS;

EID: 84875283429     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058951     Document Type: Article

References (56)

1. Rasmussen E, Cipp L, Hitzemann R, (1999) Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome 14. J Pharmacol Exp Ther 290: 1337-1346.
2. Hitzemann R, Qian Y, Kanes S, Dains K, Hitzemann B, (1995) Genetics and the organization of the basal ganglia. Int Rev Neurobiol 38: 43-94.
3. Kanes S, Dains K, Cipp L, Gatley J, Hitzemann B, et al. (1996) Mapping the genes for haloperidol-induced catalepsy. J Pharmacol Exp Ther 277: 1016-1025.
4. Iancu OD, Darakjian P, Malmanger B, Walter NA, McWeeney S, et al. (2012) Gene networks and haloperidol-induced catalepsy. Genes Brain Behav 11: 29-37.
5. Roberts A, Pardo-Manuel de Villena F, Wang W, McMillan L, Threadgill DW, (2007) The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm Genome 18: 473-481.
6. Zhang B, Horvath S, (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 4: Article17.
7. Ronnegard L, Valdar W, (2011) Detecting major genetic loci controlling phenotypic variability in experimental crosses. Genetics 188: 435-447.
8. Chen Y, Zhu J, Lum PY, Yang X, Pinto S, et al. (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452: 429-435.
9. Farber CR, (2010) Identification of a gene module associated with BMD through the integration of network analysis and genome-wide association data. J Bone Miner Res 25: 2359-2367.
10. Muers M, (2011) Systems biology: Plant networks. Nat Rev Genet 12: 586.
11. Mukhtar MS, Carvunis AR, Dreze M, Epple P, Steinbrenner J, et al. (2011) Independently evolved virulence effectors converge onto hubs in a plant immune system network. Science 333: 596-601.
12. Belknap JK, Richards SP, O'Toole LA, Helms ML, Phillips TJ, (1997) Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. Behav Genet 27: 55-66.
13. Iancu OD, Darakjian P, Walter NA, Malmanger B, Oberbeck D, et al. (2010) Genetic diversity and striatal gene networks: focus on the heterogeneous stock-collaborative cross (HS-CC) mouse. BMC Genomics 11: 585.
14. Langfelder P, Luo R, Oldham MC, Horvath S, (2011) Is my network module preserved and reproducible? PLoS Comput Biol 7: e1001057.
15. Malmanger B, Lawler M, Coulombe S, Murray R, Cooper S, et al. (2006) Further studies on using multiple-cross mapping (MCM) to map quantitative trait loci. Mamm Genome 17: 1193-1204.
16. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
17. Excoffier L, Smouse PE, Quattro JM, (1992) Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 131: 479-491.
18. Langfelder P, Horvath S, (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9: 559.
19. Langfelder P, Zhang B, Horvath S, (2008) Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 24: 719-720.
20. Vadigepalli R, Chakravarthula P, Zak DE, Schwaber JS, Gonye GE, (2003) PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 7: 235-252.
21. Mott R, Talbot CJ, Turri MG, Collins AC, Flint J, (2000) A method for fine mapping quantitative trait loci in outbred animal stocks. Proc Natl Acad Sci U S A 97: 12649-12654.
22. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
23. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
24. Barabasi AL, Bonabeau E, (2003) Scale-free networks. Sci Am 288: 60-69.
25. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264-278.
26. Moretti R, Ansari AZ, (2008) Expanding the specificity of DNA targeting by harnessing cooperative assembly. Biochimie 90: 1015-1025.
27. Bailly-Bechet M, Braunstein A, Pagnani A, Weigt M, Zecchina R, (2010) Inference of sparse combinatorial-control networks from gene-expression data: a message passing approach. BMC Bioinformatics 11: 355.
28. Keum JW, Ahn JH, Kang TJ, Kim DM, (2009) Combinatorial, selective and reversible control of gene expression using oligodeoxynucleotides in a cell-free protein synthesis system. Biotechnol Bioeng 102: 577-582.
29. Remenyi A, Scholer HR, Wilmanns M, (2004) Combinatorial control of gene expression. Nat Struct Mol Biol 11: 812-815.
30. Patel NV, Hitzemann RJ, (1999) Detection and mapping of quantitative trait loci for haloperidol-induced catalepsy in a C57BL/6J x DBA/2J F2 intercross. Behav Genet 29: 303-310.
31. Valjent E, Bertran-Gonzalez J, Herve D, Fisone G, Girault JA, (2009) Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. Trends Neurosci 32: 538-547.
32. Vadasz C, Smiley JF, Figarsky K, Saito M, Toth R, et al. (2007) Mesencephalic dopamine neuron number and tyrosine hydroxylase content: Genetic control and candidate genes. Neuroscience 149: 561-572.
33. Tang B, Di Lena P, Schaffer L, Head SR, Baldi P, et al. (2011) Genome-wide identification of Bcl11b gene targets reveals role in brain-derived neurotrophic factor signaling. PLoS ONE 6: e23691.
34. Desplats PA, Lambert JR, Thomas EA, (2008) Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease. Neurobiol Dis 31: 298-308.
35. Qian Y, Hitzemann B, Hitzemann R, (1992) D1 and D2 dopamine receptor distribution in the neuroleptic nonresponsive and neuroleptic responsive lines of mice, a quantitative receptor autoradiographic study. J Pharmacol Exp Ther 261: 341-348.
36. Qian Y, Hitzemann B, Yount GL, White JD, Hitzemann R, (1993) D1 and D2 dopamine receptor turnover and D2 messenger RNA levels in the neuroleptic-responsive and the neuroleptic nonresponsive lines of mice. J Pharmacol Exp Ther 267: 1582-1590.
37. Kanes SJ, Hitzemann BA, Hitzemann RJ, (1993) On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. J Pharmacol Exp Ther 267: 538-547.
38. Keane TM, Goodstadt L, Danecek P, White MA, Wong K, et al. (2011) Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477: 289-294.
39. Allen JD, Xie Y, Chen M, Girard L, Xiao G, (2012) Comparing statistical methods for constructing large scale gene networks. PLoS ONE 7: e29348.
40. Oldham MC, Horvath S, Geschwind DH, (2006) Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc Natl Acad Sci U S A 103: 17973-17978.
41. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, et al. (2008) Functional organization of the transcriptome in human brain. Nat Neurosci 11: 1271-1282.
42. Kim S, Cho H, Lee D, Webster MJ, (2012) Association between SNPs and gene expression in multiple regions of the human brain. Transl Psychiatry 2: 113-113.
43. Mozhui K, Wang X, Chen J, Mulligan MK, Li Z, et al. (2011) Genetic regulation of Nrnx1 expression: an integrative cross-species analysis of schizophrenia candidate genes. Transl Psychiatry 1: e25-e25.
44. Mulligan MK, Ponomarev I, Hitzemann RJ, Belknap JK, Tabakoff B, et al. (2006) Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis. Proc Natl Acad Sci U S A 103: 6368-6373.
45. Hitzemann R, (2000) Animal models of psychiatric disorders and their relevance to alcoholism. Alcohol Res Health 24: 149-158.
46. Hofstetter JR, Hitzemann RJ, Belknap JK, Walter NA, McWeeney SK, et al. (2008) Characterization of the quantitative trait locus for haloperidol-induced catalepsy on distal mouse chromosome 1. Genes Brain Behav 7: 214-223.
47. Bendesky A, Tsunozaki M, Rockman MV, Kruglyak L, Bargmann CI, (2011) Catecholamine receptor polymorphisms affect decision-making in C. elegans. Nature 472: 313-318.
48. The genome architecture of the collaborative cross mouse genetic reference population. Genetics 190: 389-401.
49. Delic S, Streif S, Deussing JM, Weber P, Ueffing M, et al. (2008) Genetic mouse models for behavioral analysis through transgenic RNAi technology. Genes Brain Behav 7: 821-830.
50. Dorval V, Hebert SS, (2012) LRRK2 in Transcription and Translation Regulation: Relevance for Parkinson's Disease. Front Neurol 3: 12.
51. French CA, Jin X, Campbell TG, Gerfen E, Groszer M, et al. (2011) An aetiological Foxp2 mutation causes aberrant striatal activity and alters plasticity during skill learning. Mol Psychiatry.
52. Li Y, Liu W, Oo TF, Wang L, Tang Y, et al. (2009) Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 12: 826-828.
53. Magen I, Chesselet MF, (2010) Genetic mouse models of Parkinson's disease The state of the art. Prog Brain Res 184: 53-87.
54. Nishi A, Snyder GL, (2010) Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: biochemical and behavioral profiles of phosphodiesterase inhibition in dopaminergic neurotransmission. J Pharmacol Sci 114: 6-16.
55. Schwindinger WF, Betz KS, Giger KE, Sabol A, Bronson SK, et al. (2003) Loss of G protein gamma 7 alters behavior and reduces striatal alpha(olf) level and cAMP production. J Biol Chem 278: 6575-6579.
56. Iancu OD, Kawane S, Bottomly D, Searles R, Hitzemann R, et al. (2012) Utilizing RNA-Seq data for de novo coexpression network inference. Bioinformatics 28: 1592-1597.